DE60140439D1 - Hybridprotein und dafür kodierender vektor zur inhibition der angiogenese - Google Patents

Hybridprotein und dafür kodierender vektor zur inhibition der angiogenese

Info

Publication number
DE60140439D1
DE60140439D1 DE60140439T DE60140439T DE60140439D1 DE 60140439 D1 DE60140439 D1 DE 60140439D1 DE 60140439 T DE60140439 T DE 60140439T DE 60140439 T DE60140439 T DE 60140439T DE 60140439 D1 DE60140439 D1 DE 60140439D1
Authority
DE
Germany
Prior art keywords
sequence
angiogenesis
inhibition
vector
vascular endothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140439T
Other languages
English (en)
Inventor
Wen G Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiff Biologicals Ltd
Original Assignee
Cardiff Biologicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiff Biologicals Ltd filed Critical Cardiff Biologicals Ltd
Application granted granted Critical
Publication of DE60140439D1 publication Critical patent/DE60140439D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
  • Color Image Communication Systems (AREA)
  • Saccharide Compounds (AREA)
DE60140439T 2000-05-04 2001-05-04 Hybridprotein und dafür kodierender vektor zur inhibition der angiogenese Expired - Lifetime DE60140439D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0010630.2A GB0010630D0 (en) 2000-05-04 2000-05-04 Sequence
PCT/GB2001/001956 WO2001083562A2 (en) 2000-05-04 2001-05-04 Hybrid protein and vector encoding the same for inhibition of angiogenesis

Publications (1)

Publication Number Publication Date
DE60140439D1 true DE60140439D1 (de) 2009-12-24

Family

ID=9890846

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140439T Expired - Lifetime DE60140439D1 (de) 2000-05-04 2001-05-04 Hybridprotein und dafür kodierender vektor zur inhibition der angiogenese

Country Status (12)

Country Link
US (2) US7247716B2 (de)
EP (1) EP1278874B1 (de)
JP (1) JP2003531600A (de)
AT (1) ATE448311T1 (de)
AU (1) AU783059C (de)
CA (1) CA2408034C (de)
DE (1) DE60140439D1 (de)
DK (1) DK1278874T3 (de)
ES (1) ES2336642T3 (de)
GB (1) GB0010630D0 (de)
PT (1) PT1278874E (de)
WO (1) WO2001083562A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013025525A1 (en) * 2011-08-12 2013-02-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for specific regulation of pyruvate dehydrogenase kinase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03130091A (ja) * 1989-06-05 1991-06-03 Toyobo Co Ltd 組換ヒト肝実質細胞増殖因子
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
SE9604731D0 (sv) 1996-12-20 1996-12-20 Tamas Bartfai Konsulting Ab A component of intercellular junctions in the endothelium
AU3908299A (en) * 1997-12-08 1999-06-28 Ontogeny, Inc. Cadherin-like polypeptides, methods and compositions related thereto
WO2000002902A1 (en) * 1998-07-13 2000-01-20 Gill Parkash S Novel inhibitors of angiogenesis and tumor growth

Also Published As

Publication number Publication date
EP1278874A2 (de) 2003-01-29
CA2408034A1 (en) 2001-11-08
GB0010630D0 (en) 2000-06-21
WO2001083562A2 (en) 2001-11-08
DK1278874T3 (da) 2010-03-29
CA2408034C (en) 2011-09-27
US7247716B2 (en) 2007-07-24
PT1278874E (pt) 2010-02-17
EP1278874B1 (de) 2009-11-11
US20040253239A1 (en) 2004-12-16
JP2003531600A (ja) 2003-10-28
AU783059B2 (en) 2005-09-22
US20060104964A1 (en) 2006-05-18
AU783059C (en) 2006-03-30
ATE448311T1 (de) 2009-11-15
AU5646401A (en) 2001-11-12
WO2001083562A3 (en) 2002-01-31
ES2336642T3 (es) 2010-04-15

Similar Documents

Publication Publication Date Title
US5817485A (en) Nucleic acids and cells for recombinant production of fibroblast growth factor-10
CA2338186A1 (en) Tumor necrosis factor-gamma
WO2000003685A3 (en) Nitrilase homologs
IL126626A (en) Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
LTIP828A (en) Nucleic acid fragment which codes for human proapolipoprotein a-1
ATE329030T1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
DE69840333D1 (de) 2-m übergang des zellzyklus
ATE399858T1 (de) Blütenorgan-spezifische promotersequenzen
ATE215988T1 (de) Vitamin-k-abhängige carboxylase
WO1997022695A3 (fr) Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer
DK1151079T3 (da) 1-deoxy-D-xylulose-5-phosphatreduktoisomerase og anvendelsesfremgangsmåder
WO2003073995A3 (en) Dna vaccine against proliferating endothelial cells and methods of use thereof.
NZ331063A (en) Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition
CA2202519A1 (en) Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
DE60140439D1 (de) Hybridprotein und dafür kodierender vektor zur inhibition der angiogenese
AR025482A1 (es) Secuencia de adn que codifica una proteina capaz de ligarse a traf; vector que comprende dicha secuencia; celulas huespedes transformadas con dicho vector;proteinas iren codificadas por dicha secuencia; metodo para producir dicha proteina; anticuerpos especificos para dichas proteinas; metodo para m
AR029627A1 (es) Derivados de proteina c y composiciones farmaceuticas formuladas con dichos derivados, moleculas de dna recombinante que codifican dichos derivados; vectores de transformacion que comprenden dichos derivados; aislados de acidos nucleicos que comprenden polinucleotidos que codifican al menos el 90% d
RU2006119452A (ru) Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
JP2002538775A5 (de)
CA2448347A1 (en) Novel human hydroxylases and polynucleotides encoding the same
Ji et al. cDNA cloning and characterization of a rat spermatogenesis-associated protein Rsp29
CA2351894A1 (en) Novel protein, gene encoding the same and method of utilization thereof
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
ES2306658T3 (es) Factor de transcripcion tif-ia de la arn polimerasa i.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition